JMI Hospital Requisite Manufacturing Limited announcements
103 Dhaka Stock Exchange announcements for JMI Hospital Requisite Manufacturing Limited (JHRML) since 2022: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (25).
- Board Approves Converting its Subsidiary into a Public Limited Company
The company has informed that the Board of Directors in its meeting held on December 02, 2025 has approved the conversion of JMI Specialized Hospital Limited, a subsidiary of JMI Hospital Requisite Manufacturing Limited, from a private limited company to a public limited company. (cont.) (Cont. News of JHRML): The Board further resolved that the Company has already invested an additional Tk. 106,070,000.00 in JMI Specialized Hospital Limited (JSHL), bringing total investment to Tk. 316,070,000.00. After discussion, the Board decided not to invest further and to reduce its shareholding below 50%, converting JSHL from a subsidiary to an associate while retaining significant influence. (end)
- Resumption after Record Date
Trading of the shares of the company will resume on 27.11.2025.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 26.11.2025.
- Qualified Opinion and Other Matters
The auditor of the company and its subsidiary has given the "Qualified Opinion" & "Other Matters" paragraph in the Auditor's Report of the company for the year ended on 30 June 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JHRML2025.pdf
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 24.11.2025 to 25.11.2025 and trading of the shares will remain suspended on record date i.e., 26.11.2025.
- Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 0.29 for July-September 2025 as against Tk. 0.55 for July-September 2024. Consolidated NOCFPS was Tk. 0.53 for July-September 2025 as against Tk. 0.14 for July-September 2024. Consolidated NAV per share was Tk. 35.42 as on September 30, 2025 and Tk. 35.14 as on June 30, 2025. (cont.) (Cont. News of JHRML): Reason for deviation: EPS has decreased mainly due to a reduction in sales, while operating expenses did not decline proportionately. In addition, the subsidiary company, JIMI Specialized Hospital Limited, has commenced its commercial operations during the period, which involved higher initial operating expenses, contributing further to the decline in overall earnings. (end)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2025 at 3:30 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
- Auditor's report regarding status of IPO Proceeds utilization
JMI Hospital Requisite Manufacturing Limited submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the period from July 01, 2025 to September 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JHRML_112025.pdf
- Dividend Declaration
The Board of Directors has recommended 5% Cash dividend only for General Shareholders excluding Sponsors & Directors for the year ended June 30, 2025. The quantities of securities held by the said sponsors and/or directors who will not be entitled to recommended dividend: 40,464,500 shares. The amount payable to the general shareholders is Tk. 4,24,14,810.00. Date of AGM: 22.01.2026, Time: 11:00 AM, Venue: Will be notified later through AGM Notice. Record Date: 26.11.2025. (cont.) (Cont. news of JHRML): The Company has also reported consolidated EPS of Tk. 1.86, consolidated NAV per share of Tk. 35.14 and consolidated NOCFPS of Tk. 2.33 for the year ended June 30, 2025 as against as against consolidated EPS of Tk. 2.34, consolidated NAV per share of Tk. 33.95 and consolidated NOCFPS of Tk. 2.36 for the year ended June 30, 2024. (end)
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (27.10.2025) following its corporate declaration.
- Regarding proposed partial change in the use of IPO proceeds
The company has informed that the Board of Directors has recommended a revision in the utilization of IPO proceeds and an extension of time up to December 31, 2026 due to additional utility expenses have been required in connection with the completion of the project. To view the details, please visit: https://www.dsebd.org/Annexure/2025/JMIHospital_202510.pdf
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2025 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
- Regarding further investment in a Subsidiary
The Board of Directors approved a further investment of Tk. 11.50 crore in its subsidiary, JMI Specialized Hospital Limited, to complete the ongoing project, purchase machinery, and support the company's working capital and other related requirements.
- Regarding inauguration of JMI Specialized Hospital Limited
The company has informed that the grand opening of JMI Specialized Hospital Limited, a licensed facility of Apollo Health and Lifestyle Limited, India (Apollo Clinic), and a 65% owned distinguished subsidiary of JMI Hospital Requisite Manufacturing Limited, one of the flagship companies of the JMI Group. (cont.) (Cont. News of JHRML): This landmark event, inaugurated on 23 August 2025, marks a significant step forward of the company's enduring commitment to delivering internationally accredited healthcare services and enhancing the overall healthcare ecosystem of Bangladesh. (end)
- Auditor's report regarding status of IPO Proceeds utilization
JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement from April 01, 2025 to June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JMI%20Hospital%20Requisite_2025.pdf
- Auditor's report regarding status of IPO Proceeds utilization
JMI Hospital Requisite Manufacturing Ltd. submitted auditor's report regarding IPO (Initial Public Offering) Proceeds utilization statement for the period from 01 January 2025 to 31 March 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JMIHospital-2025.pdf
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.50 for January-March 2025 as against Tk. 0.56 for January-March 2024; EPS was Tk. 1.56 for July 2024-March 2025 as against Tk. 1.73 for July 2023-March 2024. NOCFPS was Tk. 0.75 for July 2024-March 2025 as against Tk. 1.82 for July 2023-March 2024. NAV per share was Tk. 34.83 as on March 31, 2025 and Tk. 33.95 as on June 30, 2024. NOCFPS has been decreased because of an increase in accounts receivable and an increase in advance, deposit and prepayments in subsidiary company.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2025 at 5:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
- Sale confirmation of a Director
Mr. Md. Mohiuddin Ahmed, a Director of the company, has completed sale of his entire holding of 100,000 shares of the through Dhaka Stock Exchange PLC. as per declaration disseminated on 03.02.2025.
- Dividend Disbursement
The company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
- Category Change
The Company will be placed in 'A' category from existing 'B' category with effect from February 27, 2025 as the Company has reported disbursement of 10% Cash Dividend for the year ended June 30, 2024.
- Auditor's report regarding status of IPO Proceeds utilization
JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the quarter ended December 31, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/JMIHOSPITAL_2024.pdf
- Sale Declaration of a Director
Mr. Md. Mohiuddin Ahmed, a Director of the company, has expressed intention to sell his entire holding of 100,000 shares of the company at prevailing market price (in the Public Market) through Dhaka Stock Exchange PLC. within next 30 working days.
- Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 0.51 for October-December 2024 as against Tk. 0.63 for October-December 2023; Consolidated EPS was Tk. 1.06 for July-December 2024 as against Tk. 1.17 for July-December 2023. Consolidated NOCFPS was Tk. 0.36 for July-December 2024 as against Tk. 1.07 for July-December 2023. Consolidated NAV per share was Tk. 35.01 as on December 31, 2024 and Tk. 33.95 as on June 30, 2024. (cont.) (Cont. News of JHRML): Reasons for deviation: EPS has decreased because of the imported raw material purchases are at high prices compared with sales in the local market. NOCFPS has decreased because of an increase in accounts receivable and an increase in advance deposit and prepayment in the subsidiary company. (end)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2025 at 5:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.